Ratos AB: Biolin Scientific divests Analytical Instruments

(Thomson Reuters ONE) -


7 December 2016

Ratos subsidiary Biolin Scientific Holding AB has divested Analytical
Instruments (Biolin Scientific AB), a subsidiary in the Biolin Group, to the
listed company AddLife. The sale is not expected to generate a significant exit
gain for Ratos.

Ratos acquired Biolin Scientific in 2010, and the company currently offers
advanced analysis instruments that help scientists and enterprises to
scientifically analyse materials, nanotechnologies and pharmaceuticals faster
and better. Biolin Scientific's operations are conducted in two independent
subsidiaries today called Analytical Instruments and Drug Discovery. In
conjunction with the divestment of Analytical Instruments, Drug Discovery will
be run as an independent company in Ratos under the name Sophion, and shared
Group-wide resources will be discontinued. Analytical Instruments has about 60
employees, with annual sales of approximately SEK 100m and operating EBITA of
approximately SEK 6m based on the most recent 12 months as per September 2016.

"We have chosen to divest Analytical Instruments to AddLife, which will become a
new, long-term owner with similar operations in Life Science. At the same time,
this will enable increased focus on Sophion's core operations as an independent
company," says Christina Rubenhag, CEO of Biolin Scientific Holding.

The divestment is not expected to generate a significant exit gain for Ratos.
Sophion will be recognised as other net assets in Ratos's accounts for the full
year 2016.

For further information, please contact:
Magnus Agervald, CEO Ratos, +46 8 700 17 00
Elin Ljung, Head of Corporate Communications Ratos, +46 8 700 17 20

Financial calendar from Ratos:
Year-end report 2016                               17 February 2017

Ratos is an investment company that owns and develops unlisted medium-sized

companies in the Nordic countries. Our goal as an active owner is to contribute
to long-term and sustainable business development in the companies we invest in
and to make value-generating transactions. Ratos's portfolio consists of 20
medium-sized Nordic companies and the largest segments in terms of sales are
Consumer goods/Commerce, Construction and Industrials. Ratos is listed on Nasdaq
Stockholm and has approximately 15,500 employees.


Press release (pdf):
http://hugin.info/1180/R/2062416/773752.pdf



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ratos via GlobeNewswire

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 07.12.2016 - 08:30 Uhr
Sprache: Deutsch
News-ID 511332
Anzahl Zeichen: 3023

contact information:
Town:

Stockholm

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 174 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ratos AB: Biolin Scientific divests Analytical Instruments"
steht unter der journalistisch-redaktionellen Verantwortung von

Ratos (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Pekka Frantti new CEO of GS-Hydro ...

EuroMaint makes strategic German acquisition ...

Ratos's wholly owned subsidiary EuroMaint has signed an agreement to acquire the leading independent German train maintenance company Rail Service Management Group (RSM). The seller is Hermann Weise and the purchase price amounts to EUR 18m (Ent ...

Change in number of votes and shares ...

The recently completed non-cash issue in conjunction with the acquisition of a minority holding in Inwido Finland, resulted in an increase in the number of shares and votes in Ratos in November as set out below. The number of B shares has increased ...

Alle Meldungen von Ratos